| Date | Title | Description | Source |
| 03.04.2024 | Addex spin-off launched with USD63 million investment |
Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio ... | startuptic... |
| 13.03.2024 | IVF uncertainty aside, startups rush to offer fertility care... | AI tools, egg freezing, surrogacy, IUI, donorship, oncofertility, genetic analysis, loans, and more
... | vator.tv/n... |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood ... | The San Francisco company readies to reveal its first clinical study results in the near term
When i... | vator.tv/n... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance the... | parsers.vc... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection P... | What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M i... | hitconsult... |
| 03.08.2022 | MeiraGTx Announces Financing Agreement with Perceptive Advis... | - Credit facility is collateralized by MeiraGTx’s wholly-owned manufacturing facilities in London, U... | globenewsw... |
| 24.02.2022 | Omada Health Raises $192M to Expand Digital Therapeutics for... | What You Should Know:
– Omada Health, a chronic care integrated healthcare provider, today announced... | hitconsult... |
| 20.01.2022 | Investors disagree on whether digital health is in a bubble ... | If there were any doubts that digital health funding, especially in the U.S., is on a rocket ride st... | medcitynew... |
| 15.11.2021 | Sermonix Pharmaceuticals Closes $40 Million Series A3 Financ... | Funds will be used to further advance lasofoxifene through late-stage clinical development as a next... | globenewsw... |
| 15.11.2021 | Sermonix Pharmaceuticals Closes $40 Million Series A3 Financ... | Funds will be used to further advance lasofoxifene through late-stage clinical development as a next... | marketscre... |
| 13.05.2021 | Perceptive Advisors Closes $515M Early-Stage Biotech Fund | What You Should Know:
– Perceptive Advisors and biotech accelerator Xontogeny, focused on seed inves... | hitconsult... |
| 13.05.2021 | Cue Health Raises $235M to Scale Connected, Molecular Diagno... | What You Should Know:
– Cue Health Inc., a health technology company, today announced the closing of... | hitconsult... |
| 12.05.2021 | Perceptive Advisors Closes $515 Million Perceptive Xontogeny... | Join Transform 2021 this July 12-16. Register for the AI event of the year.
– PXV Fund II plans to l... | venturebea... |
| 12.05.2021 | Juno Diagnostics Announces Closing of $25 Million Series A F... | Join Transform 2021 this July 12-16. Register for the AI event of the year.
– Reproductive health pi... | venturebea... |
| 12.05.2021 | Juno Diagnostics Announces Closing of $25 Million Series A F... | – Reproductive health pioneers developing genetic testing solutions to dramatically improve access t... | venturebea... |
| 12.05.2021 | Perceptive Advisors Closes Fund II, at $515M | Perceptive Advisors, a NYC-based investment management firm focused on the life sciences sector, clo... | finsmes.co... |
| 12.05.2021 | Perceptive Advisors Closes $515 Million Perceptive Xontogeny... | – PXV Fund II plans to lead Series A financings in 10 to 12 early-stage life sciences companies –
– ... | venturebea... |
| 12.05.2021 | Xontogeny Announces Launch of Several New Early-Stage Portfo... | – Five new drug therapeutic companies supported with strategic and operational guidance and seed cap... | venturebea... |
| 12.05.2021 | Xontogeny Announces Launch of Several New Early-Stage Portfo... | Join Transform 2021 this July 12-16. Register for the AI event of the year.
– Five new drug therapeu... | venturebea... |
| 01.03.2021 | Agile Therapeutics, Inc. announced that it has received $45 ... | On March 1, 2021, the company amended the terms of the transaction. The company now raised $45 milli... | marketscre... |
| 08.02.2021 | Ally Bridge Portfolio News – Next-Gen Proteomics Company Nau... | Nautilus Biotechnology has entered into a definitive merger agreement with Arya Sciences Acquisition... | ally-bridg... |
| 12.01.2021 | Earli : Raises $40 Million Series A Funding Led by Khosla Ve... | The biotech industry has been aspiring to develop breakthrough technologies that hold promise for ac... | marketscre... |
| 07.01.2021 | IsoPlexis Announces $135 Million Series D Led by Perceptive ... | IsoPlexis, the leader in single-cell functional proteomics, today announced a $135 million Series D ... | citybizlis... |
| 07.01.2021 | IsoPlexis Announces $135 Million Financing Led by Perceptive... | | prnewswire... |
| 10.12.2019 | Perceptive Advisors Closes Inaugural $210 Million Perceptive... | – New fund plans to lead Series A financings in 8 to 10 companies –
– Fund will favor companies seed... | venturebea... |
| 10.12.2019 | Perceptive Advisors raises $210M for its Inaugural Fund to i... | Perceptive Advisors, an investment management firm focused in life sciences, has closed $210 for its... | techstartu... |
| 10.12.2019 | Perceptive Advisors Closes Inaugural $210 Million Perceptive... | – New fund plans to lead Series A financings in 8 to 10 companies –
– Fund will favor companies seed... | venturebea... |
| 10.12.2019 | Perceptive Advisors Closes Inaugural Fund, at $210M | Perceptive Advisors, a New York, NY-based investment management firm focused in life sciences, close... | finsmes.co... |
| 21.08.2019 | Oncorus Raises $79.5M Series B Financing Co-Led by Cowen Hea... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oncorus, Inc., an oncolytic virus company focused on driving inno... | archive.ci... |
| 21.08.2019 | Oncorus Announces $79.5 Million Series B Financing Co-Led by... | –Company advancing broad pipeline of next-generation oncolytic virus therapies for both intratumoral... | venturebea... |
| 21.08.2019 | Oncorus Raises $79.5M Series B Financing Co-Led by Cowen Hea... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oncorus, Inc., an oncolytic virus company focused on driving inno... | citybizlis... |
| 27.06.2019 | PanTheryx Raises $50 Million From Perceptive Advisors | BOULDER, Colo.--(BUSINESS WIRE)--PanTheryx, a biotechnology company focused on addressing serious GI... | citybizlis... |
| 26.06.2019 | Boulder biotech company PanTheryx gets $50 million | Boulder biotechnology company PanTheryx is getting $50 million from Perceptive Advisors to develop t... | dailycamer... |
| 07.01.2018 | Vitruvias Therapeutics Completes $11.5M Series A Led by JW A... | AUBURN, Ala.--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., a private generic pharmaceutical company... | archive.ci... |
| 07.01.2018 | Vitruvias Therapeutics Completes $11.5M Series A Led by JW A... | AUBURN, Ala.--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., a private generic pharmaceutical company... | citybizlis... |
| 21.09.2017 | Landos Biopharma Raises $10M Series A Led by Perceptive Advi... | Landos Biopharma, Inc., an emerging biopharmaceutical company focused on developing improved treatme... | citybizlis... |
| 13.09.2017 | A biotech company focused on inherited diseases just raised ... | Courtsey BridgeBio
BridgeBio CEO Neil Kumar
A biotech focused on developing drugs to treat genetic d... | businessin... |
| 19.05.2017 | Xontogeny Launches with $25M Series A Financing | Xontogeny, LLC, a Boston, MA-based new life sciences accelerator operating company focused on the ea... | finsmes.co... |
| 25.10.2016 | Perceptive Advisors Raises $323 Million Credit Opportunities... | Perceptive Advisors LLC, an investment management firm focused on the healthcare sector, today annou... | citybizlis... |
| 23.08.2016 | Romulus Capital Leads $14M Series C for Vyome Biosciences | Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines f... | citybizlis... |
| 23.08.2016 | Perceptive Advisors Leads $14M Series C for Vyome Bioscience... | Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines f... | citybizlis... |
| 22.08.2016 | Vyome Biosciences gets $14 mn from Perceptive Advisors, othe... | Delhi-based biopharmaceutical firm Vyome Biosciences Pvt. Ltd said on Monday it has received $14 mil... | vccircle.c... |
| - | Meet the 23 biotech startups that are set to take off in the... | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and s... | businessin... |
| - | Investors disagree on whether digital health is in a bubble ... | If there were any doubts that digital health funding, especially in the U.S., is on a rocket ride st... | medcitynew... |
| - | 9 top West Coast biotechs that VCs say are poised to take of... | Tayfun Coskun/Anadolu Agency/Getty Images This story is available exclusively to Insider subscribers... | businessin... |
| - | Fusion Pharmaceuticals Raises $105 Million In Oversubscribed... |
Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-parti... | healthcap.... |